Bioscan Research Raises $1 Million Seed Funding

Indian healthtech startup Bioscan Research has secured $1 million in seed funding. The round was led by venture capital firm Unicorn India Ventures.

The company stated the funds will be used to expand clinical trials and develop new diagnostic tools. Bioscan Research focuses on diagnostics and management for chronic diseases such as diabetes and cardiovascular conditions.

The technology aims to enable early detection and more accurate monitoring of diseases. This could potentially improve patient outcomes and reduce healthcare costs.

Anil Joshi, founder of Unicorn India Ventures, said the firm believes in Bioscan Research's potential to disrupt the healthcare sector in India and globally. The company has already demonstrated its capability in developing innovative solutions for challenging health issues.

Bioscan Research plans to continue testing and validating its technology in the coming months. The company intends to expand into new markets with the secured funding.